ArticleJournal of biological engineering2025
CRISPR/Cas9-mediated mutation of GhCAD decreases the gossypol content of cottonseed.
Article in Journal of biological engineering, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Cottonseed is the most important byproduct of cotton production. However, high free gossypol contents limit the application of cottonseed in the food or feed industry. In this study, CRISPR/Cas9 technology was used to knock out the (+)-δ-cadinene synthase gene (GhCAD) to decrease the gossypol content. Gossypol levels decreased approximately 64% in cottonseeds and leaves following the targeted mutation of GhCAD. If only GhCAD1-A was edited, the seed gossypol content decreased by approximately 46%, but there were no major changes in the leaf gossypol content. In addition, the protein and fatty acid (C16:0, C18:1, and C18:2) profiles of the transgenic cotton seeds were similar to those of the control cotton seeds. Furthermore, transcriptome analysis revealed that the jasmonic acid signal transduction pathway was significantly enriched among the DEGs, and GhMYC2-D09 expression was down-regulated. Silencing of GhMYC2-D09 via virus-induced gene silencing decreased the expression of gossypol biosynthesis-related genes, ultimately restricting the accumulation of gossypol in cotton leaves. In contrast, the overexpression of GhMYC2-D09 in hairy roots had the opposite effect. Dual-luciferase assays revealed that GhMYC2-D09 can activate the expression of GhCAD1-A and GhCAD1-C, but Y1H assays revealed that GhMYC2-D09 cannot bind directly to GhCAD promoters. In conclusion, we used CRISPR/Cas9 technology to silence GhCAD expression and developed new genetic resources for generating low-gossypol cotton materials. Furthermore, we characterized GhMYC2-D09 as a transcription factor that increases gossypol biosynthesis. These findings may provide new insights to further elucidate the regulatory network of gossypol biosynthesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.